Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Lululemon (LULU) Stock Sinks As Market Gains: Here's Why
Lululemon (LULU) Stock Sinks As Market Gains: Here's Why

In the latest close session, Lululemon (LULU) was down 2.64% at $195.19. The stock's change was less than the S&P 500's daily gain of 0.03%. Elsewhere, the Dow lost 0.03%, while the tech-heavy

Li Auto Inc. Sponsored ADR (LI) Stock Sinks As Market Gains: Here's Why
Li Auto Inc. Sponsored ADR (LI) Stock Sinks As Market Gains: Here's Why

In the latest trading session, Li Auto Inc. Sponsored ADR (LI) closed at $23.75, marking a -4.62% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.03%

ZIM Integrated Shipping Services (ZIM) Stock Falls Amid Market Uptick: What Investors Need to Know
ZIM Integrated Shipping Services (ZIM) Stock Falls Amid Market Uptick: What Investors Need to Know

ZIM Integrated Shipping Services (ZIM) closed at $16.96 in the latest trading session, marking a -2.58% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.03%

Harmony Gold (HMY) Stock Sinks As Market Gains: What You Should Know
Harmony Gold (HMY) Stock Sinks As Market Gains: What You Should Know

Harmony Gold (HMY) closed at $15.26 in the latest trading session, marking a -1.23% move from the prior day. This change lagged the S&P 500's 0.03% gain on the day. At the same time, the Dow lost

Macy's (M) Stock Sinks As Market Gains: Here's Why
Macy's (M) Stock Sinks As Market Gains: Here's Why

In the latest close session, Macy's (M) was down 1.89% at $12.96. The stock trailed the S&P 500, which registered a daily gain of 0.03%. On the other hand, the Dow registered a loss of 0.03%, and

Carnival (CCL) Stock Dips While Market Gains: Key Facts
Carnival (CCL) Stock Dips While Market Gains: Key Facts

In the latest trading session, Carnival (CCL) closed at $30.25, marking a -1.27% move from the previous day. This move lagged the S&P 500's daily gain of 0.03%. Meanwhile, the Dow experienced a drop

Zscaler (ZS) Stock Sinks As Market Gains: Here's Why
Zscaler (ZS) Stock Sinks As Market Gains: Here's Why

Zscaler (ZS) ended the recent trading session at $270.99, demonstrating a -2.44% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.03%. Meanwhile, the Dow

Beam Global (BEEM) Reports Q2 Loss, Lags Revenue Estimates
Beam Global (BEEM) Reports Q2 Loss, Lags Revenue Estimates

Beam Global (BEEM) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.14 per share a year ago. These figures are

ESS Tech, Inc. (GWH) Reports Q2 Loss, Lags Revenue Estimates
ESS Tech, Inc. (GWH) Reports Q2 Loss, Lags Revenue Estimates

ESS Tech, Inc. (GWH) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estimate of a loss of $0.88. This compares to a loss of $1.8 per share a year ago. These figures are

Gambling.com Group Limited (GAMB) Q2 Earnings and Revenues Beat Estimates
Gambling.com Group Limited (GAMB) Q2 Earnings and Revenues Beat Estimates

Gambling.com Group Limited (GAMB) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.2 per share a year

Strattec Security (STRT) Beats Q4 Earnings and Revenue Estimates
Strattec Security (STRT) Beats Q4 Earnings and Revenue Estimates

Strattec Security (STRT) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.39 per share a year ago. These

Cibus (CBUS) Reports Q2 Loss, Lags Revenue Estimates
Cibus (CBUS) Reports Q2 Loss, Lags Revenue Estimates

Cibus (CBUS) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to a loss of $1.14 per share a year ago. These figures are

Dragonfly Energy Holdings Corp. (DFLI) Reports Q2 Loss, Tops Revenue Estimates
Dragonfly Energy Holdings Corp. (DFLI) Reports Q2 Loss, Tops Revenue Estimates

Dragonfly Energy Holdings Corp. (DFLI) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $1.29. This compares to a loss of $1.98 per share a year

Deere’s Sell-Off Could Be a Long-Term Buying Chance
Deere’s Sell-Off Could Be a Long-Term Buying Chance

Deere & Co. (NYSE: DE) stock is dropping sharply after it lowered its full-year guidance, citing tariff uncertainty, cautious customer spending, and weaker crop prices. The stock was down more

Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates
Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates

Plus Therapeutics (PSTV) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.71 per share a year ago. These

Compared to Estimates, Applied Materials (AMAT) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Applied Materials (AMAT) Q3 Earnings: A Look at Key Metrics

Applied Materials (AMAT) reported $7.3 billion in revenue for the quarter ended July 2025, representing a year-over-year increase of 7.7%. EPS of $2.48 for the same period compares to $2.12 a year

Genasys (GNSS) Reports Q3 Loss, Beats Revenue Estimates
Genasys (GNSS) Reports Q3 Loss, Beats Revenue Estimates

Genasys (GNSS) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.15 per share a year ago. These figures are

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.46 per share versus the Zacks Consensus Estimate of a loss of $6.4. This compares to a loss of $11.2 per share a year ago

IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates

IGC Pharma, Inc. (IGC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.03 per share a year ago. These figures

RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates
RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates

RenovoRx, Inc. (RNXT) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.1 per share a year ago. These figures are adjusted

Evolv Technologies Holdings, Inc. (EVLV) Reports Q2 Loss, Beats Revenue Estimates
Evolv Technologies Holdings, Inc. (EVLV) Reports Q2 Loss, Beats Revenue Estimates

Evolv Technologies Holdings, Inc. (EVLV) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.02 per share a year

Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates
Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates

Profound Medical (PROF) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.28 per share a year ago. These figures

Guidance Watch: 2 Companies Bullishly Raising Forecasts
Guidance Watch: 2 Companies Bullishly Raising Forecasts

The 2025 Q2 earnings cycle is slowly winding down, which has been resilient so far.

For the 457 S&P 500 companies that have reported Q2 results as of August 13th, total earnings are up +11.6% from

P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates

P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago. These

MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates

MacroGenics (MGNX) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $0.89 per share a year ago. These figures are